These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 2872804

  • 1. Terazosin: an effective once-daily monotherapy for the treatment of hypertension.
    Dauer AD.
    Am J Med; 1986 May 23; 80(5B):29-34. PubMed ID: 2872804
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
    Deger G.
    Am J Med; 1986 May 23; 80(5B):62-7. PubMed ID: 2872809
    [Abstract] [Full Text] [Related]

  • 3. Comparative trials of terazosin with other antihypertensive agents.
    Ruoff G.
    Am J Med; 1986 May 23; 80(5B):42-8. PubMed ID: 2872806
    [Abstract] [Full Text] [Related]

  • 4. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG.
    Am J Med; 1986 May 23; 80(5B):55-61. PubMed ID: 2872808
    [Abstract] [Full Text] [Related]

  • 5. Cumulative experience with terazosin administered in combination with diuretics.
    Rudd P.
    Am J Med; 1986 May 23; 80(5B):49-54. PubMed ID: 2872807
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blocker.
    Abraham PA, Halstenson CE, Matzke GR, Napier JL, Keane WF.
    Pharmacotherapy; 1985 May 23; 5(5):285-9. PubMed ID: 2866492
    [Abstract] [Full Text] [Related]

  • 7. Long-term experience with terazosin for treatment of mild to moderate hypertension.
    Mersey JH.
    Am J Med; 1986 May 23; 80(5B):68-72. PubMed ID: 2872810
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of intravenous terazosin in hypertensive patients. A preliminary report.
    Cohen A.
    Am J Med; 1986 May 23; 80(5B):86-93. PubMed ID: 2872814
    [Abstract] [Full Text] [Related]

  • 9. Effect of terazosin on serum lipids.
    Deger G.
    Am J Med; 1986 May 23; 80(5B):82-5. PubMed ID: 2872813
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical trials with terazosin. General methods.
    Sperzel WD, Luther RR, Glassman HN.
    Am J Med; 1986 May 23; 80(5B):25-8. PubMed ID: 2872803
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relationship between terazosin dose and blood pressure response in hypertensive patients.
    Achari R, Hosmane B, Bonacci E, O'Dea R.
    J Clin Pharmacol; 2000 Oct 23; 40(10):1166-72. PubMed ID: 11028256
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapy.
    Luther RR, Glassman HN, Sperzel WD, Steinberg FJ, Horton JK, Jordan DC.
    J Hypertens Suppl; 1986 Dec 23; 4(5):S494-7. PubMed ID: 2883273
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertension.
    Luther RR, Glassman HN, Estep CB, Schmitz PJ, Horton JK, Jordan DC.
    Am J Hypertens; 1988 Jul 23; 1(3 Pt 3):237S-240S. PubMed ID: 2901267
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.